Why Biotech? Why Amgen?
I recently visited Amgen’s research center in Denmark, where Head of Parallel Chemistry Mathilde Daugaard shared with me details of our unique approach to small-molecule drug discovery.

Why Biotech? Why Amgen?

Want to make a difference in the world??Whether you’re a newly-minted college graduate looking for your first job or someone already in the workforce searching for a more meaningful career, think about the biotechnology industry – and Amgen in particular.?Here are three reasons why:

First, biotech companies are bringing forward extraordinary innovation – right when the world needs it most.?We are living in the “biocentury” – a time that will be characterized by dramatic advances in our understanding of human biology and how to prevent and treat serious diseases affecting hundreds of millions of people. ?We’ll need the best science we can get, too, given demographic trends around the world.?There are already 700 million people worldwide over the age of 65, and another 150 million people headed there by the end of the decade. ?This will drive massive global demand for medicines from seniors confronting diseases of the aging process like heart disease, inflammation, cancer, and osteoporosis – diseases for which Amgen already offers innovative medicines and is advancing potential new treatments through our research and development pipeline.?

?Second, growth prospects for the best biotech companies remain impressive. ?Over the past few years, billions of dollars flowed into the biotech industry, enabling lots of start-ups to toss around lots of money and fancy titles.?That’s quickly changing now and, to paraphrase the legendary investor Warren Buffett, it’s only when the tide goes out that you learn who’s been swimming without a bathing suit.?Amgen has been in business for more than 40 years.?We’re one of the world’s original biotech companies and now rank as one of the largest – having seen thousands of companies come and go in between.?We have strong growth prospects in the coming years, which should enable us to continue investing in our business and in our people.?To give just one example, we invested $4.8 billion in research and development last year, seeking to advance medicines that make a big difference in the fight against serious diseases.?You can read more about our growth strategy here . ?

Third and most important, biotech companies are doing work that truly matters. ?The pandemic has left many people searching for work that has meaning.?Those of us in the biotech industry wake up every morning knowing that our work is helping millions of people live longer, healthier, happier lives.?Many of these people are our family and friends, our neighbors and coworkers.?This is not an abstraction, it’s personal.?And we have so much work still to do.?Despite the progress we’ve made, heart disease claims 18 million lives a year, while cancer takes another 10 million. ?To engage directly in the fight against serious diseases like these is enormously fulfilling.?I believe that helps to explain why Amgen has earned so many recognitions as a great place to work , including being named one of "America's Best Large Employers" by Forbes magazine earlier this year.?

To explore the wide range of opportunities we have available, please visit our Careers page on Amgen.com. ? It truly is an exciting time for our industry and for our company.??

Abhinayaa Ananthsuryanarayana

Research Scientist I - Neuro-oncology | Penn State Alum | Moderna

2 年

Inspiring note on the essence of the biotech industry in the 21st century! Looking forward to joining the vibrant research team at #Amgen real soon!

回复
narimeta jayaprakash

Dy.Finance Manager at The Singareni Collieries Company Limited

2 年

Wish and hope to produce and supply at cheapest rate to needy patients

Sophia Swire

Founder at GEDI, investing in talented women entrepreneurs

2 年

Excellent! And re-posted…

回复
Mathilde Daugaard

Principal Scientist - Manager of the Parallel Chemistry Group at Amgen Research Copenhagen

2 年

It was a pleasure to show you around our laboratories at Amgen Research Copenhagen. Your passion and engagement with our team was very motivating and inspiring. Thank you so much for finding time to visit.

回复

I have worked for small companies (myself) and for very large (Sanofi). For the majority of people starting out I would recommend a medium to large. You will learn better in a structured environment and get to work with top notch scientists. After a while you can transition to a small company if you like the idea of wearing many hats. I’ve worked with several ex-Amgen employees and never heard any complaints.

要查看或添加评论,请登录

Bob Bradway的更多文章

  • Helping to Build a Better World

    Helping to Build a Better World

    Last year, Amgen reached some 10 million patients around the world with our medicines, helping to prevent or treat…

    2 条评论
  • During American Heart Month, Let’s Recommit to Cardiovascular Health

    During American Heart Month, Let’s Recommit to Cardiovascular Health

    February is American Heart Month, a good time to remind ourselves of the ongoing threat posed by heart and vascular…

    1 条评论
  • Looking Back With Gratitude – And Forward With Optimism

    Looking Back With Gratitude – And Forward With Optimism

    As 2022 draws to a close, it’s a great time to look back on the terrific work that’s been done by my Amgen colleagues…

    10 条评论
  • Saluting Our Veterans

    Saluting Our Veterans

    On this Veterans Day, I want to thank the many Amgen employees who have served in the armed forces. They are a source…

    9 条评论
  • Inspiring the Next Generation of Innovators

    Inspiring the Next Generation of Innovators

    We recently published Amgen’s latest Environmental, Social & Governance (ESG) Report, highlighting the many things our…

  • A Holiday Treat for Patients

    A Holiday Treat for Patients

    The past several days have brought good news for millions of Americans suffering from two serious inflammatory…

    1 条评论
  • Predict and Prevent: The Right Prescription for Tackling Chronic Disease

    Predict and Prevent: The Right Prescription for Tackling Chronic Disease

    If COVID-19 has shown us anything, it’s that we can move with near-lightning speed to tackle health challenges when the…

  • LUMAKRAS? Receives FDA Approval

    LUMAKRAS? Receives FDA Approval

    Today is a big day for Amgen and, more importantly, for patients with lung cancer. The U.

    55 条评论
  • Breathing through a straw…

    Breathing through a straw…

    For most of us, breathing comes effortlessly. We don’t give it any thought – we just do it.

    3 条评论
  • Let’s Keep the U.S. Biopharmaceutical Industry Strong

    Let’s Keep the U.S. Biopharmaceutical Industry Strong

    If COVID-19 has shown us anything, it’s that the world needs more new medicines to prevent and treat disease, not…

    5 条评论

社区洞察

其他会员也浏览了